Neurocrine Biosciences (NBIX) Debt US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt, bln rub | 440.4 | 262.9 | 428.4 | 455.1 | 415.3 | 406.2 | |||
| Changes by years, y/y, % | +7% | -40% | +63% | +6% | -9% | +0.1% | |||
Neurocrine Biosciences. Debt, bln rub
Neurocrine Biosciences. Debt, changes, %
Neurocrine Biosciences (NBIX) Debt US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt, bln rub | 447.5 | 439.1 | 908.1 | 415.3 | 406.2 | 406.2 | ||
| Changes by years, y/y, % | -13% | +71% | +261% | -9% | -9% | |||
| Changes by quarters, q/q, % | -2% | -2% | +107% | -54% | -2% | |||